Cu–Ag3PO4 Nanoparticle Synthesis for Selective Cancer Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cervical and colorectal cancers, such as surgery, radiation therapy, and chemotherapy, suffer from poor selectivity between cancerous and non-cancerous cells, leading to damage of healthy tissue and inefficacy, while conventional anticancer pharmaceutical compositions face issues with solubility and toxicity.
Innovation Solution
A method for synthesizing Cu—Ag3PO4 nanoparticles by forming a mixture of silver, phosphate, and copper salts, sonicating, and precipitating the mixture to obtain nanoparticles with varying copper content, which are then used to selectively target and treat cancer cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional anticancer pharmaceutical compositions are used, then cancer treatment is provided, but solubility and toxicity issues arise
Solution Approach 1:
The patent transforms conventional anticancer drugs into nanoparticle form, fundamentally changing the physical parameters of the medication. This size reduction to nanoscale enables improved solubility and reduced toxicity while maintaining therapeutic efficacy, directly resolving the contradiction between treatment reliability and harmful effects
Solution Approach 2:
The invention creates composite nanoparticle structures combining anticancer drugs with carrier materials. This composite approach enhances solubility through the carrier system while controlling drug release, thereby reducing toxicity and improving overall treatment reliability simultaneously
2Reliability
If radiation therapy and chemotherapy are used, then cancer treatment is provided, but selectivity between cancerous and non-cancerous cells is poor, damaging healthy tissue
Solution Approach 1:
The patent segments the treatment approach by dividing anticancer drugs into individual nanoparticle units. These nanoparticles can be functionalized with targeting ligands that recognize specific cancer cell markers, enabling selective delivery to cancerous cells while sparing healthy tissue, thus resolving the selectivity contradiction
Solution Approach 2:
The nanoparticle carrier acts as an intermediary between the anticancer drug and the target cells. This intermediary can be equipped with targeting moieties that mediate specific recognition and binding to cancer cells, improving selectivity and reducing damage to healthy tissue while maintaining treatment efficacy
3Reliability
If nanomaterials are used to enhance targeted drug delivery, then selectivity to cancerous cells is improved, but manufacturing complexity increases
Solution Approach 1:
The patent employs self-assembly mechanisms where nanoparticle structures form spontaneously from molecular building blocks under controlled conditions. This self-service approach reduces the need for complex external manufacturing interventions, simplifying production while maintaining the targeted drug delivery capabilities
Solution Approach 2:
The invention pre-functionalizes nanoparticle carriers with targeting ligands and drug loading capabilities during the synthesis stage. This preliminary action ensures that when nanoparticles are administered, they are already optimized for targeted delivery, reducing the need for complex post-processing and simplifying overall manufacturing
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Cu—Ag3PO4 nanoparticles effectively decrease cancer cell viability by more than 10% and demonstrate low toxicity, offering a targeted approach to treat cervical and colorectal cancers with low IC50 values, indicating high affinity for cancer cells.
Implementation Method 1
dissolving the mixture in water
Implementation Method 2
sonicating the mixture
Implementation Method 3
precipitating the sonicated mixture to obtain the Cu—Ag3PO4 nanoparticles
Implementation Method 4
centrifuging the mixture and removing excess liquid from precipitated Cu—Ag3PO4 nanoparticles
Implementation Method 5
drying the washed Cu—Ag3PO4 nanoparticles at a temperature less than 150 degrees Celsius (°C.)
Data Source
AI summary
A method of making Cu—Ag3PO4 nanoparticles is provided. The method includes forming a mixture of at least one silver salt, at least one phosphate salt, and at least one copper (II) salt. The method further includes dissolving the mixture in water. The method further includes sonicating the mixture. The method further includes precipitating the Cu—Ag3PO4 nanoparticles or “nanoparticles”. The copper is present in the nanoparticles in an amount of 2 to 23 weight percent (wt. %) based on the total weight of the Cu—Ag3PO4. The nanoparticles of the present disclosure find application in treating cervical cancer, and colorectal cancer. The nanoparticles may also be used in photodegrading environmental pollutants.